21 May 2009
Minimal invasive methods for treatment of lymphocele after kidney transplantation
Z Ziętek, I Iwan-Ziętek, T Sulikowski, M Nowacki, M Romanowski, L Zair, M Wiśniowski, D Rość, M OstrowskiAnn Transplant 2009; 14(1): 47-47 :: ID: 880372
Abstract
Background: One of the most often occurring complications after kidney
transplantation is a lymphocele. The aim of our work was an analysis of incidence of lymphocele and the effectiveness of minimal invasive methods of treatment.
Material/Methods: The examined group was consisted of one hundred and
eighteen patients (90 male and 68 female) with the end stage renal disease (ESRD).
Results: 21 patients (13%) developed symptoms of lymphocele after transplantation within an average time of 34 weeks. The clinical symptoms included: decrease of 24-hour urine output, increase in a creatinine level abdominal discomfort, lymphorrhoea with a surgical wound dehiscence, urgency and vesical tenesmus, febrile state and deep vein thrombosis. The lymphocele was noticed in patients with excessive bleeding during transplantation, in patients with diabetic nephropathy, congenital malformations of the urinary tract, inflammatory diseases, including glomerule and extraglomerule nephropathy, after RTG-therapy and after removal of the renal graft. The efficient methods of treatment were: percutaneous aspiration with recurrence of 100%, percutaneous drainage guided by ultrasound - 55%, laparoscopic intraabdominal marsupialisation (85% good results) and a classic surgical intervention with favourable results.
Conclusions: A percutaneous drainage guided ultrasound should be recommended as the first line of treatment. As a minimal invasive surgery this kind of treatment does not interfere with subsequent internal drainage trough open or laparoscopic surgery. Laparoscopy is a feasible and safe technique
and should be used routinely after unsuccessful percutaneous drainage.
Keywords: Kidney Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






